Torrealba Jose R, Katayama Masaaki, Fechner John H, Jankowska-Gan Ewa, Kusaka Satoshi, Xu Qingyong, Schultz Jacqueline M, Oberley Terry D, Hu Huaizhong, Hamawy Majed M, Jonker Margreet, Wubben Jacqueline, Doxiadis Gaby, Bontrop Ronald, Burlingham William J, Knechtle Stuart J
Department of Pathology, University of Wisconsin and Veterans Affairs Hospital, Madison, WI 53792, USA.
J Immunol. 2004 May 1;172(9):5753-64. doi: 10.4049/jimmunol.172.9.5753.
Approaches that prevent acute rejection of renal transplants in a rhesus monkey model were studied to determine a common mechanism of acceptance. After withdrawal of immunosuppression, all 14 monkeys retained normal allograft function for >6 mo. Of these, nine rejected their renal allograft during the study, and five maintained normal function throughout the study period. The appearance of TGF-beta 1(+) interstitial mononuclear cells in the graft coincided with a nonrejection histology, whereas the absence/disappearance of these cells was observed with the onset of rejection. Analysis with a variety of TGF-beta 1-reactive Abs indicated that the tolerance-associated infiltrates expressed the large latent complex form of TGF-beta 1. Peripheral leukocytes from rejecting monkeys lacking TGF-beta 1(+) allograft infiltrates responded strongly to donor Ags in delayed-type hypersensitivity trans-vivo assays. In contrast, allograft acceptors with TGF-beta 1(+) infiltrates demonstrated a much weaker peripheral delayed-type hypersensitivity response to donor alloantigens (p < 0.01 vs rejectors), which could be restored by Abs that either neutralized active TGF-beta 1 or blocked its conversion from latent to active form. Anti-IL-10 Abs had no restorative effect. Accepted allografts had CD8(+) and CD4(+) interstitial T cell infiltrates, but only the CD4(+) subset included cells costaining for TGF-beta 1. Our data support the hypothesis that the recruitment of CD4(+) T regulatory cells to the allograft interstitium is a final common pathway for metastable renal transplant tolerance in a non-human primate model.
为确定移植肾接受的共同机制,研究了在恒河猴模型中预防肾移植急性排斥反应的方法。停用免疫抑制后,所有14只猴子的同种异体移植肾功能均正常维持超过6个月。其中,9只猴子在研究期间排斥其肾移植,5只在整个研究期间维持正常功能。移植肾中转化生长因子β1(TGF-β1)阳性间质单核细胞的出现与非排斥组织学表现一致,而在排斥反应开始时观察到这些细胞缺失/消失。用多种TGF-β1反应性抗体分析表明,与耐受相关的浸润细胞表达TGF-β1的大潜伏复合物形式。在迟发型超敏反应体内试验中,缺乏TGF-β1阳性移植肾浸润细胞的排斥猴子的外周血白细胞对供体抗原反应强烈。相反,具有TGF-β1阳性浸润细胞的移植肾接受者对供体同种异体抗原的外周迟发型超敏反应明显较弱(与排斥者相比,p<0.01),这可通过中和活性TGF-β1或阻断其从潜伏形式转化为活性形式的抗体恢复。抗白细胞介素10抗体没有恢复作用。被接受的同种异体移植肾有CD8(+)和CD4(+)间质T细胞浸润,但只有CD4(+)亚群包含TGF-β1共染色的细胞。我们的数据支持这样的假说,即CD4(+)调节性T细胞募集到同种异体移植肾间质是在非人灵长类动物模型中实现稳定肾移植耐受的最终共同途径。